• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2016 Fiscal Year Final Research Report

Optimal immunosuppressive therapy after living liver transplantation in adult

Research Project

  • PDF
Project/Area Number 26461929
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field General surgery
Research InstitutionTokyo Women's Medical University

Principal Investigator

Ogata Satoshi  東京女子医科大学, 医学部, 助教 (40444583)

Project Period (FY) 2014-04-01 – 2017-03-31
Keywords生体肝移植 / 免疫モニタリング / 免疫抑制剤
Outline of Final Research Achievements

Infection or rejection following living liver transplantation often causes critical liver dysfunction with insufficient hepatic capacity in the early postoperative period. Therefore, immunosuppressive induction therapy in living liver transplantation requires more strict postoperative management than whole liver transplantation. We attempted to reduce complications by using immunosuppressive induction therapy with tacrolimus, methylprednisolone and MMF after liver transplantation, in particular using lower dose tacrolimus. As a result, the incidence of rejection was acceptable, establishing a protocol that is less than that of renal dysfunction, postoperative glucose tolerance, which is a side effect of calcineurin inhibitor.

Free Research Field

肝胆膵外科、肝臓移植外科

URL: 

Published: 2018-03-22  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi